Please check your internet connection and try again.
# ACE Inhibitors
## Overview
ACE inhibitors are a class of medications that block the action of angiotensin-converting enzyme, leading to vasodilation and reduced aldosterone secretion. This results in decreased blood pressure and reduced workload on the heart.
## Primary Indications
* Hypertension
* Heart failure (systolic dysfunction)
* Post-myocardial infarction (MI) (left ventricular dysfunction)
* Diabetic nephropathy
* Proteinuric chronic kidney disease
## Adult Dosing
Dosing is highly variable by specific agent, indication, and patient factors. Titration is generally required.
* **Hypertension:**
* Benazepril: Start 10 mg once daily, titrate up to 40 mg once daily.
* Captopril: Start 25 mg twice daily, titrate up to 150 mg twice daily.
* Enalapril: Start 5 mg once or twice daily, titrate up to 40 mg once or twice daily.
* Fosinopril: Start 10 mg once daily, titrate up to 40 mg once daily.
* Lisinopril: Start 10 mg once daily, titrate up to 40 mg once daily.
* Moexipril: Start 7.5 mg once daily, titrate up to 30 mg once daily.
* Perindopril: Start 5 mg once daily, titrate up to 10 mg once daily.
* Quinapril: Start 10 mg once or twice daily, titrate up to 80 mg once or twice daily.
* Ramipril: Start 2.5 mg once daily, titrate up to 10 mg once daily.
* Trandolapril: Start 1 mg once daily, titrate up to 8 mg once daily.
* **Heart Failure:** Dosing varies significantly. Generally started at a lower dose and titrated upwards as tolerated.
* **Post-MI:** Generally started within 24 hours of MI if hemodynamically stable. Specific doses vary by agent.
## Pediatric Dosing
ACE inhibitors are used in pediatrics for hypertension and sometimes heart failure. Dosing is weight-based and requires careful titration. Exact dosing depends on local protocol and specific agent.
* **Captopril:** 0.3 mg/kg/dose to 0.5 mg/kg/dose every 8 to 12 hours. Maximum dose varies by indication.
* **Enalapril:** 0.07 mg/kg/dose once daily to 0.21 mg/kg/dose twice daily. Maximum dose varies by indication.
* **Lisinopril:** 0.07 mg/kg/dose once daily. Maximum dose varies by indication.
## Dose Adjustments
* **Renal Impairment:** Dose reduction is usually necessary, particularly in severe renal impairment. Specific guidelines vary by agent. Monitor serum creatinine and potassium.
* **Hepatic Impairment:** Use with caution. Dose adjustments may be needed, especially for prodrugs like enalapril and ramipril.
## Contraindications
* History of angioedema related to ACE inhibitor therapy.
* Concomitant use with aliskiren in patients with diabetes mellitus or renal impairment.
* Pregnancy (Category D in 2nd and 3rd trimesters; contraindicated).
## Adverse Effects
* Cough (dry, persistent)
* Hypotension, dizziness
* Hyperkalemia
* Angioedema (rare but life-threatening, particularly affecting face, lips, tongue, glottis, and intestines)
* Renal insufficiency (especially in patients with bilateral renal artery stenosis)
* Fatigue, headache
* Rash
## Key Drug Interactions
* **Potassium-sparing diuretics, potassium supplements, salt substitutes:** Increased risk of hyperkalemia.
* **NSAIDs:** May reduce antihypertensive effect and increase risk of renal dysfunction.
* **Diuretics (especially thiazide diuretics):** Increased risk of hypotension, particularly with initial doses.
* **Lithium:** ACE inhibitors can increase lithium levels, leading to toxicity.
* **mTOR inhibitors (e.g., sirolimus, everolimus):** Increased risk of angioedema.
* **ARBs and Aliskiren:** Increased risk of hyperkalemia, hypotension, and renal dysfunction. Avoid concomitant use in high-risk patients.
## Monitoring
* Blood pressure (before and during therapy)
* Serum potassium (baseline and periodically)
* Serum creatinine and BUN (baseline and periodically)
* Signs and symptoms of angioedema
* For patients with heart failure, monitor for worsening symptoms, volume status, and electrolytes.
## Clinical Pearls
* Cough is a common adverse effect and is usually dose-dependent and reversible upon discontinuation.
* Angioedema is a medical emergency. Patients should be instructed to discontinue the medication immediately and seek emergency care if it occurs.
* Initiate therapy at a low dose and titrate slowly, especially in patients with heart failure, the elderly, or those on diuretics.
* Monitor renal function and potassium closely, particularly in patients with pre-existing renal disease or other risk factors.
* ACE inhibitors are generally safe and effective in diabetic patients, and can help prevent or slow the progression of diabetic nephropathy.
***
*This information is intended for educational purposes and does not substitute for professional medical advice. Always consult with a qualified healthcare provider to confirm the accuracy and applicability of this information to your specific situation. Prescribing information can change; always verify with the most current official drug labeling.*